Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age

Exclusion Criteria

• •1. Subjects whose parents or legal guardians are unwilling or unable to give written informed consent to participate in the study.
• •2. History of previous immunization with a vaccine containing any of the 5 antigen components of investigational vaccine.
• •3. History of anaphylactic shock(immediate hypersensitivity reactions), urticaria or other allergic reactions after previous vaccination or known hypersensitivity to any vaccine component.
• •4. Administration of parenteral immunoglobulin preparation and/or blood products since birth.